AACI to Recognize Pioneers in Research, Philanthropy at Annual Meeting This Fall

On Monday, October 1, AACI will present two awards highlighting the importance of scientific discovery and philanthropic support in the cancer community.

Charles M. Perou, PhDCharles M. Perou, PhD, will receive AACI’s Distinguished Scientist Award in recognition of his accomplishments in the field of precision medicine and his groundbreaking research in characterizing the diversity of human tumors, which has profoundly impacted the treatment of patients with breast cancer.

The May Goldman Shaw Distinguished Professor of Molecular Oncology at UNC Lineberger Comprehensive Cancer Center, Dr. Perou is also the faculty director of UNC Lineberger’s Bioinformatics Group, co-director of its Breast Cancer Research Program, and a professor in its Genetics and Pathology & Laboratory Medicine departments.

Richard and Susan Rogel will be presented with the inaugural Champion for Cures Award in honor of their transformational philanthropy in support of cancer research and care.Richard and Susan Rogel

AACI established the Champion for Cures Award to recognize individuals who demonstrate significant leadership in supporting efforts to cure cancer. Earlier this year, the Rogels pledged $150 million to the University of Michigan Comprehensive Cancer Center, which was renamed Rogel Cancer Center.

Their gift—the largest in the University of Michigan’s history—will fund endowed professorships, competitive research grants, and scholarships, and will help the cancer center establish a collaborative network that will bring international experts to campus for 6 to 12 months to develop innovative new projects.

“Donors are an integral part of the ecosystem of cancer care,” said AACI President Stanton L. Gerson, MD, director of Case Comprehensive Cancer Center. “AACI wanted to honor a family like the Rogels, who’ve demonstrated their commitment to the success of the cancer center through their investment in research.”

The award presentations are a highlight of the AACI/CCAF Annual Meeting, scheduled September 30 – October 2 in Chicago. The event convenes AACI cancer center directors and executive-level administrators with leaders of national cancer research and advocacy groups, industry, and government health agencies to develop solutions to common challenges and to share best practices.

Register for the AACI/CCAF Annual Meeting.
View the meeting program.

Advertisements

Know an HPV Vaccination Champion in Your Community?

Nominate Them Today!

hpv-champion-ad-200x300AACI has partnered with the Centers for Disease Control and Prevention’s (CDC) National Center for Immunization and Respiratory Diseases (NCIRD) and the American Cancer Society (ACS) to recognize leaders in health care who are going above and beyond to promote or foster HPV vaccination among adolescents in their communities.

NCIRD’s HPV Vaccine Is Cancer Prevention campaign works to improve clinician quality of HPV vaccination recommendations for 11- and 12-year-olds and to increase parent acceptance of the HPV vaccine for their children.

To nominate a physician for the Champion Award, please submit a completed form by this Friday, August 10. Self-nominations are welcome.

Nominations should be submitted to the immunization programs of the state or territory in which the nominee resides. Submissions should include a completed nomination form and an image of the nominee, which may be used for promotional purposes if the nominee is selected as a Champion.

Submissions must be sent to PreteenVaccines@cdc.gov. CDC will review and confirm the recommendations and issue the awards.

Learn more about the HPV vaccine and how it can protect 11- and 12-year-olds from six different types of cancer later in life.

 

Member Spotlight: August 2018

Louisiana Cancer Research Consortium of New Orleans at the Stanley S. Scott Cancer Center and Tulane Cancer Center 

Louisiana Cancer Research Consortium

Founded in 2002 under the direction of the Louisiana State Legislature, the Louisiana Cancer Research Center’s mission is to promote education and conduct research in the diagnosis, detection, and treatment of cancer, while pursuing a National Cancer Institute designation.

The center includes more than 200 researchers representing inter- and intradisciplinary activity across the member institutions. Its strengths include molecular genetics and signaling; proteomics; immunology, infection, and inflammation; viral oncology; drug discovery; and minority health and health disparities.

Dartmouth-Hitchcock Norris Cotton Cancer Center

Norris Cotton Cancer Center

Dartmouth-Hitchcock Norris Cotton Cancer Center, in Lebanon, New Hampshire, is one of only 49 NCI-Designated Comprehensive Cancer Centers in the country. About 250 active research projects are part of the center’s quest to cure cancer, understand its causes, and promote ways to prevent cancer before it starts.

These projects are led by 135 cancer research scientists supported by more than $68 million in grants each year from federal and other sources.

Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center 

Mays Cancer Center

Thanks to a $30 million legacy gift from the Mays Family Foundation and a partnership with the MD Anderson Cancer Center, the newly-renamed Mays Cancer Center at UT Health San Antonio MD Anderson now brings the people of San Antonio the combined strengths of UT Health San Antonio and MD Anderson’s expertise in multidisciplinary, research-driven, patient-centered care.

Mays is one of four NCI-Designated Cancer Centers in Texas.